People
NIVI Development will facilitate the translational efforts of NIVI by providing industry-level expertise in vaccine development and conducting the early clinical testing of our vaccine candidates.
Meet the team
Bridging research, translational sciences, and development
NIVI Development will catalyse progress towards achieving the NIVI mission by enabling access to cutting-edge technologies and data-driven approaches to design, test, and optimise novel vaccine candidates. NIVI Development provides capabilities and expertise – either directly, or via external strategic partnerships – to bridge exploratory research and clinical (Phase 1 & 2, including CHIM) translational development.
Hocine William Mankouri
Interim Managing Director
Email:
[email protected]
Niels Thulstrup
Chief Business Officer
Email:
[email protected]
Mike Whelan
Head of PMO
Email:
[email protected]
Morten Ruhwald
Chief Medical Officer
Email:
[email protected]
Jane Ellen Elvekjaer
Personal Assistant to CEO
Email:
[email protected]
Rasmus L. Krogh-Meyer
Director of Business Development
Email:
[email protected]